SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Vivani Medical Reports Third Quarter 2026 Financial Results and Provides Business Update

Top-line results for SLIM-1™, the first-in-human Phase 1 trial of NPM-139, Vivani's miniature, ultra

VANI

Related stories